CG&D
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Thomassen, E.
Right arrow Articles by Werenskiold, A. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Thomassen, E.
Right arrow Articles by Werenskiold, A. K.

Cell Growth & Differentiation, Vol 6, Issue 2 179-184, Copyright © 1995 by American Association of Cancer Research


ARTICLES

Role of cell type-specific promoters in the developmental regulation of T1, an interleukin 1 receptor homologue

E Thomassen, G Kothny, S Haas, J Danescu, L Hultner, P Dormer and AK Werenskiold
Abt. Zellchemie, GSF-Forschungszentrum fur Umwelt und Gesundheit, Neuherberg, Federal Republic of Germany.

Murine T1, an orphan receptor related to interleukin 1 receptors, exhibits a bimodal expression in mouse development. The molecular analysis of cultured cell lines now reveals the contribution of alternate promoters of the T1 gene to its differential expression. In nonhemopoietic cell types, where T1 synthesis in vivo is restricted to organogenesis and neoplasia, a recently characterized AP-1-dependent promoter directs a proliferation-associated expression of the gene. In hemopoietic cells, which express the T1 receptor throughout ontogenesis in vivo, T1 gene activity is driven by a novel serum factor-independent, constitutive promoter. The tissue-specific use of constitutive versus growth factor-dependent alternate promoters thus directs the permanent activity of the T1 gene in hemopoietic tissue versus the developmentally restricted expression of the gene in nonhemopoietic tissues in vivo.


This article has been cited by other articles:


Home page
J. Immunol.Home page
Y.-f. Gu, Y. Fang, Y. Jin, W.-r. Dong, L.-x. Xiang, and J.-z. Shao
Discovery of the DIGIRR Gene from Teleost Fish: A Novel Toll-IL-1 Receptor Family Member Serving as a Negative Regulator of IL-1 Signaling
J. Immunol., September 1, 2011; 187(5): 2514 - 2530.
[Abstract] [Full Text] [PDF]


Home page
J Biol ChemHome page
M. A. Gayle, J. L. Slack, T. P. Bonnert, B. R. Renshaw, G. Sonoda, T. Taguchi, J. R. Testa, S. K. Dower, and J. E. Sims
Cloning of a Putative Ligand for the T1/ST2 Receptor
J. Biol. Chem., March 8, 1996; 271(10): 5784 - 5789.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cell Growth & Differentiation
Copyright © 1995 by the American Association of Cancer Research.